|
Do-Coop Technologies expects that the first clinical applications of its Neowater offering, a water-based biomaterial, are likely to be incorporated into commercial diagnostic assays within 2006. Neowater is currently available in an increasing range of research market applications. However, the company contends that its technology could have a revolutionary effect on parameter optimization including repeatability, sensitivity, efficiency, and miniaturization, as well as costs in clinical diagnostics and life science research. Neowater may also eventually do away with the many barriers that limit development, formulation, efficacy and delivery of biotherapeutics and pharmaceuticals. Neowater is made up of a stable system of highly hydrated, inert nanoparticles, which alter the physical properties of water molecules nearby. Then, as with non-ionic detergent-derived micelles, the entropy of an aqueous solution is reduced. Neowater's hydrophobic and hydrophilic properties are the result of the combination of the free water molecules and hydrated nanoparticles. Neowater appears to be essentially water, but its behavior is of a strong detergent. The material is stable at room temperature and can be sheered, boiled, and frozen. The company has initially targeted Neowater to the research market to allow as many labs as possible to witness the benefits for themselves.
|
Information Sources, Inc.
![[Get Copyright Permissions]](http://license.icopyright.net/images/icopy-w.gif){kind=small}